Annual Shareholders Equity
$2.22 M
-$1.78 M-44.49%
31 December 2023
Summary:
XTL Biopharmaceuticals annual stockholders equity is currently $2.22 million, with the most recent change of -$1.78 million (-44.49%) on 31 December 2023. During the last 3 years, it has fallen by -$1.39 million (-38.54%). XTLB annual shareholders equity is now -95.73% below its all-time high of $51.95 million, reached on 31 December 2001.XTLB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$2.71 M
+$485.00 K+21.85%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly stockholders equity is currently $2.71 million, with the most recent change of +$485.00 thousand (+21.85%) on 31 March 2024. Over the past year, it has increased by +$204.00 thousand (+8.16%). XTLB quarterly shareholders equity is now -90.88% below its all-time high of $29.66 million, reached on 30 June 2006.XTLB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.5% | +8.2% |
| 3 y3 years | -38.5% | -12.2% |
| 5 y5 years | -69.5% | -66.6% |
XTLB Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -58.4% | at low | -53.7% | +21.9% |
| 5 y | 5 years | -69.5% | at low | -66.6% | +21.9% |
| alltime | all time | -95.7% | >+9999.0% | -90.9% | +652.0% |
XTL Biopharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $2.71 M(+21.8%) |
| Dec 2023 | $2.22 M(-44.5%) | $2.22 M(-11.2%) |
| Sept 2023 | - | $2.50 M(-8.0%) |
| June 2023 | - | $2.72 M(-11.8%) |
| Mar 2023 | - | $3.08 M(-23.0%) |
| Dec 2022 | $4.00 M(-25.0%) | $4.00 M(-15.7%) |
| Sept 2022 | - | $4.74 M(-14.7%) |
| June 2022 | - | $5.56 M(-4.8%) |
| Mar 2022 | - | $5.84 M(+9.6%) |
| Dec 2021 | $5.33 M(+47.6%) | $5.33 M(+73.2%) |
| Sept 2021 | - | $3.08 M(-6.2%) |
| June 2021 | - | $3.28 M(-24.8%) |
| Mar 2021 | - | $4.37 M(+20.9%) |
| Dec 2020 | $3.61 M(-44.6%) | $3.61 M(-40.1%) |
| Sept 2020 | - | $6.03 M(-8.6%) |
| June 2020 | - | $6.59 M(-6.1%) |
| Mar 2020 | - | $7.03 M(+7.8%) |
| Dec 2019 | $6.51 M(-10.4%) | $6.51 M(-19.5%) |
| Sept 2019 | - | $8.09 M(-13.4%) |
| June 2019 | - | $9.35 M(-23.4%) |
| Mar 2019 | - | $12.20 M(+67.7%) |
| Dec 2018 | $7.27 M(+101.0%) | $7.27 M(+0.0%) |
| Sept 2018 | - | $7.27 M(+16.6%) |
| June 2018 | - | $6.24 M(+0.7%) |
| Mar 2018 | - | $6.20 M(+71.2%) |
| Dec 2017 | $3.62 M(+34.7%) | $3.62 M(-0.0%) |
| Sept 2017 | - | $3.62 M(+73.2%) |
| June 2017 | - | $2.09 M(-40.3%) |
| Mar 2017 | - | $3.50 M(+30.3%) |
| Dec 2016 | $2.69 M(-45.0%) | $2.69 M(-29.8%) |
| Sept 2016 | - | $3.83 M(-6.2%) |
| June 2016 | - | $4.08 M(-7.0%) |
| Mar 2016 | - | $4.39 M(-10.3%) |
| Dec 2015 | $4.89 M | $4.89 M(-32.3%) |
| Sept 2015 | - | $7.22 M(-5.3%) |
| June 2015 | - | $7.63 M(+64.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $4.64 M(-0.5%) |
| Dec 2014 | $4.66 M(-25.6%) | $4.66 M(-13.6%) |
| Sept 2014 | - | $5.39 M(-5.5%) |
| June 2014 | - | $5.71 M(-7.1%) |
| Mar 2014 | - | $6.14 M(-2.0%) |
| Dec 2013 | $6.26 M(-14.8%) | $6.26 M(-14.4%) |
| Sept 2013 | - | $7.32 M(+16.7%) |
| June 2013 | - | $6.28 M(-8.1%) |
| Mar 2013 | - | $6.83 M(-7.2%) |
| Dec 2012 | $7.35 M(+113.5%) | $7.35 M(+0.4%) |
| Sept 2012 | - | $7.32 M(+12.6%) |
| June 2012 | - | $6.51 M(-5.2%) |
| Mar 2012 | - | $6.86 M(+99.2%) |
| Dec 2011 | $3.44 M(+21.5%) | $3.44 M(-7.4%) |
| Sept 2011 | - | $3.72 M(-7.9%) |
| June 2011 | - | $4.04 M(-6.0%) |
| Mar 2011 | - | $4.30 M(+51.7%) |
| Dec 2010 | $2.83 M(>+9900.0%) | $2.83 M(-8.8%) |
| Sept 2010 | - | $3.11 M(-734.3%) |
| June 2010 | - | -$490.00 K(+120.7%) |
| Mar 2010 | - | -$222.00 K(-3271.4%) |
| Dec 2009 | $7000.00(-99.5%) | $7000.00(-97.1%) |
| Sept 2009 | - | $240.00 K(-83.7%) |
| Dec 2008 | $1.47 M(-82.8%) | $1.47 M(-46.3%) |
| June 2008 | - | $2.75 M(-67.9%) |
| Dec 2007 | $8.56 M(-62.4%) | $8.56 M(-5.7%) |
| June 2007 | - | $9.08 M(-60.1%) |
| Dec 2006 | $22.76 M(+102.3%) | $22.76 M(-23.3%) |
| June 2006 | - | $29.66 M(+163.6%) |
| Dec 2005 | $11.25 M(-42.6%) | $11.25 M(-25.7%) |
| June 2005 | - | $15.14 M(-22.7%) |
| Dec 2004 | $19.60 M(-4.9%) | $19.60 M(+86.4%) |
| June 2004 | - | $10.52 M |
| Dec 2003 | $20.61 M(-40.8%) | - |
| Dec 2002 | $34.83 M(-33.0%) | - |
| Dec 2001 | $51.95 M | - |
FAQ
- What is XTL Biopharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual shareholders equity year-on-year change?
- What is XTL Biopharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly shareholders equity year-on-year change?
What is XTL Biopharmaceuticals annual stockholders equity?
The current annual shareholders equity of XTLB is $2.22 M
What is the all time high annual shareholders equity for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual stockholders equity is $51.95 M
What is XTL Biopharmaceuticals annual shareholders equity year-on-year change?
Over the past year, XTLB annual stockholders equity has changed by -$1.78 M (-44.49%)
What is XTL Biopharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of XTLB is $2.71 M
What is the all time high quarterly shareholders equity for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly stockholders equity is $29.66 M
What is XTL Biopharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, XTLB quarterly stockholders equity has changed by +$204.00 K (+8.16%)